OMEGA THERAPEUTICS INC (OMGA)
US68217N1054 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 68.44M | 70.60M | 186.50M | 23.00M | 2.30M | |||
| Marketable Securities | 4.99M | 54.10M | 38.80M | N/A | N/A | |||
| Receivables | 6.99M | 1.80M | 500.00K | 200.00K | 0.00 | |||
| Other Current Assets | 9.47M | 11.10M | 3.40M | 900.00K | 400.00K | |||
| Total Current Assets | 89.88M | 137.60M | 229.30M | 24.00M | 2.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 114.05M | 7.90M | 3.60M | 3.50M | 2.80M | |||
| Other Non-Current Assets | 435.00K | 500.00K | 400.00K | 600.00K | 600.00K | |||
| Total Non-Current Assets | 114.48M | 8.40M | 4.00M | 4.10M | 3.40M | |||
| TOTAL ASSETS | 204.37M | 146.00M | 233.30M | 28.10M | 6.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.00M | 3.30M | 0.00 | 3.00M | 0.00 | |||
| Accrued Expenses | 18.59M | 14.90M | 9.00M | 3.10M | 1.10M | |||
| Accounts Payable | 1.62M | 3.10M | 2.10M | 1.10M | 900.00K | |||
| Other Current Liabilities | 2.60M | 600.00K | 900.00K | 600.00K | 200.00K | |||
| Total Current Liabilities | 26.81M | 22.00M | 12.00M | 7.70M | 2.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 14.88M | 16.60M | 19.90M | 8.70M | 11.90M | |||
| Other Non-Current Liabilities | 104.66M | 1.50M | 900.00K | 1.10M | 1.20M | |||
| Total Non-Current Liabilities | 119.54M | 18.00M | 20.70M | 9.80M | 13.10M | |||
| TOTAL LIABILITIES | 146.35M | 40.00M | 32.70M | 17.50M | 15.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -334.63M | -237.20M | -134.50M | -66.20M | -36.80M | |||
| Additional Paid In Capital | 392.61M | 343.60M | 335.10M | 1.60M | 900.00K | |||
| Common Shares | 55.00K | 0.00 | 0.00 | 75.20M | 26.70M | |||
| Other Shareholders' Equity | -14.00K | -500.00K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 55.14M | 48.10M | 47.80M | 46.70M | 46.70M | |||
| Tangible Book Value per Share | 1.05 | 2.20 | 4.20 | -1.38 | -0.77 | |||
| Total Shareholders' Equity | 58.02M | 106.00M | 200.60M | 10.60M | -9.20M | |||
| TOTAL LIABILITIES AND EQUITY | 204.37M | 146.00M | 233.30M | 28.10M | 6.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.26 | 0.16 | 0.10 | 0.82 | -1.29 | |||
| Current Ratio | 3.35 | 6.25 | 19.11 | 3.12 | 1.23 | |||
| Return On Assets (ROA) | -47.67% | -70.34% | -29.27% | -104.80% | -294.26% | |||
| Return On Equity (ROE) | -167.93% | -96.89% | -34.04% | -277.83% | N/A | |||
All data in USD